Recent advances in technology have enabled 3D printing of biocompatible parts, driving major innovations in the medical industry. At the same time, 3D bioprinting has raised a number of legal questions, including patent eligibility under Section 101. In this podcast, Finnegan attorneys Barbara R. Rudolph and Kai Rajan provide insight into intellectual property concerns around 3D bioprinting.

Click here todownload podcast.